Sphingolipids in anticancer therapy

被引:32
作者
Padrón, JM
机构
[1] Hosp Univ NS Candelaria, Inst Canario Invest Canc, Unidad Invest, Santa Cruz de Tenerife 38010, Spain
[2] Red Temat Invest Cooperat Ctr Canc, Inst Canario Invest Canc, Santa Cruz de Tenerife 38010, Spain
[3] Univ La Laguna, Inst Univ Bioorgan Antonio Gonzalez, E-38206 San Cristobal la Laguna, Spain
关键词
sphingolipid analogs; sphingosine; ceramide; apoptosis; signal transduction; anticancer drugs; structure-activity relationships; drug design;
D O I
10.2174/092986706776055553
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Sphingolipids constitute a broad class of compounds with many biological functions. The sphingolipid metabolites ceramide and sphingosine are potent apoptosis inducers and produce cell cycle arrest, whereas sphingosine-1-phosphate promotes cellular growth and differentiation. Herein, the effects of sphingolipids and their analogs on diverse signaling pathways implicated in the apoptotic process are highlighted. The relatively simple chemical structure of these compounds has led to several strategies for their total synthesis. Those methods have contributed to the development and biological study of several analogs that present diverse degree of modification from the original structure. This article catalogues many of the recently developed synthetic analogs that act on diverse aspects of sphingolipid metabolism. A description of known enzyme inhibitors of the sphigolipids pathway is also given. Finally, diverse new sphingolipid-like antitumor agents isolated from marine sources are presented. This contribution opens the way for future development of new sphingolipid analogs that might be useful in cancer chemotherapy.
引用
收藏
页码:755 / 770
页数:16
相关论文
共 168 条
  • [71] Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes - Involvement of the sphingolipid signaling cascade in cardiac cell death
    Krown, KA
    Page, MT
    Nguyen, C
    Zechner, D
    Gutierrez, V
    Comstock, KL
    Glembotski, CC
    Quintana, PJE
    Sabbadini, RA
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (12) : 2854 - 2865
  • [72] Pachastrissamine, a cytotoxic anhydrophytosphingosine from a marine sponge, Pachastrissa sp.
    Kuroda, I
    Musman, M
    Ohtani, II
    Ichiba, T
    Tanaka, J
    Gravalos, DG
    Higa, T
    [J]. JOURNAL OF NATURAL PRODUCTS, 2002, 65 (10): : 1505 - 1506
  • [73] Sphingosine-l-phosphate and lipid phosphohydrolases
    Le Stunff, H
    Peterson, C
    Liu, H
    Milstien, S
    Spiegel, S
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2002, 1582 (1-3): : 8 - 17
  • [74] Jaspines A and B:: two new cytotoxic sphingosine derivatives from the marine sponge Jaspis sp.
    Ledroit, V
    Debitus, C
    Lavaud, C
    Massiot, G
    [J]. TETRAHEDRON LETTERS, 2003, 44 (02) : 225 - 228
  • [75] Chemistry and biology of sphingolipids
    Liao, JY
    Tao, JH
    Lin, GQ
    Liu, DG
    [J]. TETRAHEDRON, 2005, 61 (20) : 4715 - 4733
  • [76] Ataxia telangiectasia-mutated gene product inhibits DNA damage-induced apoptosis via ceramide synthase
    Liao, WC
    Haimovitz-Friedman, A
    Persaud, RS
    McLoughlin, M
    Ehleiter, D
    Zhang, N
    Gatei, M
    Lavin, M
    Kolesnick, R
    Fuks, Z
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (25) : 17908 - 17917
  • [77] Sphingolipid metabolism in the regulation of bioactive molecules
    Luberto, C
    Hannun, YA
    [J]. LIPIDS, 1999, 34 : S5 - S11
  • [78] Lucci A, 1999, INT J ONCOL, V15, P541
  • [79] Design, synthesis, and characterization of the antitumor activity of novel ceramide analogues
    Macchia, M
    Barontini, S
    Bertini, S
    Di Bussolo, V
    Fogli, S
    Giovannetti, E
    Grossi, E
    Minutolo, F
    Danesi, R
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (23) : 3994 - 4000
  • [80] Macchia Marco, 2003, Farmaco (Lausanne), V58, P85, DOI 10.1016/S0014-827X(02)00002-2